InvestorsHub Logo
Followers 0
Posts 54
Boards Moderated 0
Alias Born 05/05/2006

Re: None

Sunday, 08/06/2006 12:27:54 PM

Sunday, August 06, 2006 12:27:54 PM

Post# of 3723
MrSparex, Thanks for the opportunity to assist you on this board, I will try to be of some value along the way, I believe by years end we may have our hands full as we proceed into stage III clinicals and the traders begin to discover what's happening here, just imagine the market potential, I believe I read that the market for Viagra, Cialis etc. is around 6 billion a year? And two thirds of men that could benefit from this kind of therapy can NOT use the current products due to it's mechanism which acts on the vascular system, soooo, another potential 12 billion or so for Bremelanotide which is so far proven to be completely safe for these men? And how many more billions for the some 40% of women who suffer some form of sexual dysfunction who currently have no product to turn to? Yes, this is an exciting product for sure, as I said before though, caution is advised as always, we are dealing with a biotech after all.

MrSparex, take a look at MCZ when you have a chance, the chart is very similar, it has taken a beating due to the rundown to the end of the current console's life cycles, and is in the doldrums still as we transition to the new models (PS-3, x-box 360 etc), I still believe they have a viable business model, if only for another few years, they dropped a licensing agreement last year that was costing them quite a bit of cash, and I believe are positioned somewhat better to do well as Christmas approaches and the new consoles spur the video game buyers again, they recently hit a pretty significant bottom and I am up comfortably from my buys in the low .30's. May be worth a poker bet, especially if they test the lows again, but of course ANY stock this cheap is risky, so caution is again advised, some more DD is needed I believe.

Cheers! Lego
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PTN News